Development of Group B Streptococcal vaccine to alleviate emerging antibiotic resistance through elimination of current prophylactic antibiotic strategies in GBS prevention.

Project Information

NEOSTREP

Grant agreement ID: 601743

Project closed

Start date 1 July 2013

End date 31 October 2016

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 891 808,20

EU contribution € 5 999 172,00

Coordinated by

LUNDS UNIVERSITET
Sweden